MoneyWorks4Me

Jenburkt Pharmaceuticals informs about loss of share certificate

13 Dec 2023 Evaluate
Jenburkt Pharmaceuticals has informed that the information received from shareholder regarding loss of share certificate received on today, 13th December, 2023, is enclosed. This is in the process of issuing Letter of Confirmation, after compliance of required formalities.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..